Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Europe aquaculture vaccines industry summary, 2016 – 2027

2.1.1    Business trends

2.1.2    Type of vaccines trends

2.1.3    Route of administration trends

2.1.4    Application trends

2.1.5    Species trends

2.1.6    Country trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2016 - 2027

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1    Surging prevalence of viral and bacterial infections

3.3.1.2    Increasing aquaculture production in the region

3.3.1.3    Development and launch of new aquaculture vaccines

3.3.1.4    Rising adoption of aquaculture vaccines against antibiotics

3.3.2    Industry pitfall and challenges

3.3.2.1    Stringent regulatory policies for vaccine approval

3.3.2.2    Complex vaccine development procedures

3.4    Growth potential analysis

3.4.1    By type of vaccines

3.4.2    By route of administration

3.4.3    By application

3.4.4    By species

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive review, 2019

3.8    PEST analysis

Chapter 4   Europe Aquaculture Vaccines Market, By Type of Vaccines

4.1    Key trends in Europe aquaculture vaccines market, by technology

4.2    Inactivated vaccines

4.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.3    Live vaccines

4.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.4    Others

4.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 5   Europe Aquaculture Vaccines Market, By Route of Administration

5.1    Key trends in Europe aquaculture vaccines market, by route of administration

5.2    Immersion vaccines

5.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.3    Injection vaccines

5.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.4    Oral vaccines

5.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 6   Europe Aquaculture Vaccines Market, By Application

6.1    Key trends in Europe aquaculture vaccines market, by application

6.2    Bacterial infection

6.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

6.3    Viral infection

6.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

6.4    Others

6.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 7   Europe Aquaculture Vaccines Market, By Species

7.1    Key trends in Europe aquaculture vaccines market, by species

7.2    Salmon

7.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.3    Trout

7.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.4    Tilapia

7.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 8   Europe Aquaculture Vaccines Market, By Country

8.1    Key trends in Europe Aquaculture Vaccines market, by country

8.2    Germany

8.2.1.1    Market size, by country, 2016- 2027

8.2.1.2    Market size, by route of administration, 2016- 2027

8.2.1.3    Market size, by application, 2016- 2027

8.2.1.4    Market size, by species, 2016 - 2027

8.3    UK

8.3.1.1    Market size, by country, 2016- 2027

8.3.1.2    Market size, by route of administration, 2016- 2027

8.3.1.3    Market size, by application, 2016- 2027

8.3.1.4    Market size, by species, 2016 – 2027

8.4    France

8.4.1.1    Market size, by country, 2016- 2027

8.4.1.2    Market size, by route of administration, 2016- 2027

8.4.1.3    Market size, by application, 2016- 2027

8.4.1.4    Market size, by species, 2016 – 2027

8.5    Spain

8.5.1.1    Market size, by country, 2016- 2027

8.5.1.2    Market size, by route of administration, 2016- 2027

8.5.1.3    Market size, by application, 2016- 2027

8.5.1.4    Market size, by species, 2016 – 2027

8.6    Italy

8.6.1.1    Market size, by country, 2016- 2027

8.6.1.2    Market size, by route of administration, 2016- 2027

8.6.1.3    Market size, by application, 2016- 2027

8.6.1.4    Market size, by species, 2016 – 2027

8.7    Norway

8.7.1.1    Market size, by country, 2016- 2027

8.7.1.2    Market size, by route of administration, 2016- 2027

8.7.1.3    Market size, by application, 2016- 2027

8.7.1.4    Market size, by species, 2016 – 2027

8.8    Ireland

8.8.1.1    Market size, by country, 2016- 2027

8.8.1.2    Market size, by route of administration, 2016- 2027

8.8.1.3    Market size, by application, 2016- 2027

8.8.1.4    Market size, by species, 2016 – 2027

8.9    Turkey

8.9.1.1    Market size, by country, 2016- 2027

8.9.1.2    Market size, by route of administration, 2016- 2027

8.9.1.3    Market size, by application, 2016- 2027

8.9.1.4    Market size, by species, 2016 – 2027

8.10    Denmark

8.10.1.1    Market size, by country, 2016- 2027

8.10.1.2    Market size, by route of administration, 2016- 2027

8.10.1.3    Market size, by application, 2016- 2027

8.10.1.4    Market size, by species, 2016 – 2027

8.11    Greece

8.11.1.1    Market size, by country, 2016- 2027

8.11.1.2    Market size, by route of administration, 2016- 2027

8.11.1.3    Market size, by application, 2016- 2027

8.11.1.4    Market size, by species, 2016 – 2027

8.12    The Netherlands

8.12.1.1    Market size, by country, 2016- 2027

8.12.1.2    Market size, by route of administration, 2016- 2027

8.12.1.3    Market size, by application, 2016- 2027

8.12.1.4    Market size, by species, 2016 – 2027

8.13    Finland

8.13.1.1    Market size, by country, 2016- 2027

8.13.1.2    Market size, by route of administration, 2016- 2027

8.13.1.3    Market size, by application, 2016- 2027

8.13.1.4    Market size, by species, 2016 – 2027

8.14    Sweden

8.14.1.1    Market size, by country, 2016- 2027

8.14.1.2    Market size, by route of administration, 2016- 2027

8.14.1.3    Market size, by application, 2016- 2027

8.14.1.4    Market size, by species, 2016 – 2027

8.15    Poland

8.15.1.1    Market size, by country, 2016- 2027

8.15.1.2    Market size, by route of administration, 2016- 2027

8.15.1.3    Market size, by application, 2016- 2027

8.15.1.4    Market size, by species, 2016 – 2027

Chapter 9   Company Profiles

9.1    Hipra

9.1.1    Business overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.2    Zoetis Inc.

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.3    Merck & Co., Inc.

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.4    Tecnovax

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.5    Virbac

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.6    Veterquimica S.A.

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.7    Nisseiken Co. Ltd.

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    Strategic outlook